Fig. 5: Discovery and validation of atypical subpopulations in triple-negative breast cancer (TNBC) and luminal A patients.

a Sankey plot showing the distribution of patients in the seven subpopulations vs. clinical subtypes. b Kaplan-Meier (KM) survival plot for the two TNBC subpopulations in the single-cell dataset and the differentially expressed protein biomarkers for the two subpopulations. c Validation of the two TNBC subpopulations in TCGA breast cancer data corresponding to those in (b) by KM plot and differentially expressed genes. d Validation of the two TNBC subpopulations in METABRIC breast cancer data corresponding to those in (b) by KM plot and differentially expressed genes. e KM survival plot for the two luminal A subpopulations in the single-cell dataset and the differentially expressed protein biomarkers for the two subpopulations. f Validation of the two luminal A subpopulations in TCGA breast cancer data corresponding to those in (e) by KM plot and differentially expressed genes. g Validation of the two luminal A subpopulations in METABRIC breast cancer data corresponding to those in (e) by KM plot and differentially expressed genes. (For each subplot, the blue curve represents the subpopulation in context).